CPHI News & Events

China Pharma Holdings reported that it expects to implement a 1-for-10 reverse stock split on its common stock effective Tuesday, April 15, with trading to begin on a split-adjusted basis at the market open on that day. Trading in the common stock will continue on the NYSE American under the symbol "CPHI". The new CUSIP number for the common stock following the reverse stock split is 16941T 401.

China Pharma Holdings announced that it has filed a prospectus supplement with the U.S. SEC under which the company may offer and sell from time to time shares of common stock with an aggregate offering price of up to $600,000. The shares will be offered pursuant to a certain Securities Purchase Agreement the company entered into with certain investor on December 12. Pursuant to the SPA, the Investor agrees to, at its discretion, purchase, from time to time over the commitment period from December 12 through December 31, through one or more closings, up to $600,000 worth of the common stock, at the prices related to prevailing market prices, which equals to the lower of (i) the closing price the day prior to the purchase notice, or (ii) the five (5) day average closing prices of the company as reported by Bloomberg or on the NYSE American Market's website and in accordance with NYSE Rule Section 312.03(c), provided, in no event shall the price per share be lower than 15c per share.